SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-796199
Filing Date
2016-12-19
Accepted
2016-12-16 20:57:32
Documents
4
Period of Report
2016-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d309784d8k.htm 8-K 16415
2 EX-1.1 d309784dex11.htm EX-1.1 181664
3 EX-99.1 d309784dex991.htm EX-99.1 8273
4 GRAPHIC g309784g20q10.gif GRAPHIC 5111
  Complete submission text file 0001193125-16-796199.txt   214701
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 162057683
SIC: 2834 Pharmaceutical Preparations